A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study
<p><strong>Background: </strong>Data to support individualised choice of optimal glucose-lowering therapy are scarce for people with type 2 diabetes. We aimed to establish whether routinely available clinical features can be used to predict the relative glycaemic effectiveness of f...
| 主要な著者: | , , , , |
|---|---|
| その他の著者: | |
| フォーマット: | Journal article |
| 言語: | English |
| 出版事項: |
Elsevier
2025
|